Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma.
Ontology highlight
ABSTRACT: Myeloid cells comprise the majority of immune cells in tumors, contributing to tumor growth and therapeutic resistance. Incomplete understanding of myeloid cells response to tumor driver mutation and therapeutic intervention impedes effective therapeutic design. Here, by leveraging CRISPR/Cas9-based genome editing, we generate a mouse model that is deficient of all monocyte chemoattractant proteins. Using this strain, we effectively abolish monocyte infiltration in genetically engineered murine models of de novo glioblastoma (GBM) and hepatocellular carcinoma (HCC), which show differential enrichment patterns for monocytes and neutrophils. Eliminating monocyte chemoattraction in monocyte enriched PDGFB-driven GBM invokes a compensatory neutrophil influx, while having no effect on Nf1-silen
SUBMITTER: Chen Z
PROVIDER: S-EPMC10070461 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA